Sydney South West Area Health Service Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2003
NCT00120601
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

acamprosate (campral) (1 trial)

naltrexone (revia) (1 trial)

Drugs in Phase 2 Trials (1)

lithium (lithonate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 4)

Marijuana Abuse (Phase 2)

Substance Withdrawal Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3